Helius Medical Technologies Inc HSDT

Technology Scientific & Technical Instruments

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.

NDAQ:HSDT - Post by User

Helius Medical Technologies Inc

Bullboard Posts

Post by steelinvestoron Mar 14, 2019 4:57pm

166 Views

Post# 29487914

Positive Summary

Very pleased to hear HSM has;

A) submitted their response to the FDA's request for additional information

B) recording approx $500K in revenue

C) estimating up to $2MM in revenue for 2019

These are all very good developments however, I do wish though that Helius/Phil would aggresivly respond to the Diamond/Alpha/short report. Many point made by them are factually wrong and not pushing back with the facts may only serve to give that report value/life.

Bullboard Posts

The top 10 Canadian medical stocks